CHU de Reims - Hôpital Robert Debré

Paris, Île-de-France Region 75019

1 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory KMT2A-r Acute Leukemia, Relapsed/Refractory NPM1-m Acute Leukemia, Relapsed/Refractory NUP98-r Acute Leukemia

Studies at this site

• Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia — Recruiting now